$FRX Recent Headlines Earnings boost Micron, dra

$FRX Recent Headlines

Earnings boost Micron, drag on Container Store 4:25 p.m. Jan. 8, 2014 - Sue Chang
U.S. stocks end lower after Fed minutes 4:24 p.m. Jan. 8, 2014 - Anora Mahmudova
Stock market live blog (recap): Dow, S&P 500 end lower after Fed minutes 4:04 p.m. Jan. 8, 2014 - blogs.marketwatch.com
Forest shares see double-digit gains following Aptalis purchase 11:03 a.m. Jan. 8, 2014 - Russ Britt
Forest Laboratories acquires Aptalis for $2.9 bln 7:50 a.m. Jan. 8, 2014 - Saumya Vaishampayan
Forest Laboratories acquires Aptalis for $2.9 bln 7:45 a.m. Jan. 8, 2014 - Saumya Vaishampayan
Facebook, Twitter, Yahoo are stocks to watch 1:57 p.m. Dec. 24, 2013 - Wallace Witkowski
Stocking stuffer stocks for 2014 10:52 a.m. Dec. 23, 2013 - The Trading Deck
S&P shifts to ‘good news is good news’ backdrop 12:14 p.m. Dec. 9, 2013 - Michael Ashbaugh
Dow set to open below 16,000; Apple rises 8:53 a.m. Dec. 3, 2013 - William L. Watts
Forest Laboratories to cut 9% of workforce 11:39 p.m. Dec. 2, 2013 - MarketWatch.com
EBay outperforms Amazon on Cyber Monday 4:16 p.m. Dec. 2, 2013 - Sue Chang
Cuts, stock buyback, acquisition combine to boost Forest shares 11:09 a.m. Dec. 2, 2013 - Russ Britt
Forest Labs to cut $500 mln in costs, R&D 9:55 a.m. Dec. 2, 2013 - MarketWatch.com
Apple snaps winning streak; Netflix rewinds 3:59 p.m. Oct. 22, 2013 - Sue Chang
Changing of the guard at Forest Labs placates Icahn — for now 3:50 p.m. Sept. 10, 2013 - Russ Britt
Forest Labs Fetzima Gets FDA OK on depression drug 8:06 a.m. July 26, 2013 - MarketWatch.com
Forest Labs investors see the light; swing shares to a gain near close 2:38 p.m. July 23, 2013 - Russ Britt
Centene, Forest each beat earnings views, but diverge in market woods 10:16 a.m. July 23, 2013 - Russ Britt
Forest Labs net falls 58% on lower Lexapro sales 7:06 a.m. July 23, 2013 - MarketWatch.com


Why Forest Laboratories (FRX) is Poised to Beat Earnings Estimates Again - Tale of the Tape 8:45 a.m. Today - Zacks.com
Ironwood Up on Job Cut Plans - Analyst Blog 6:30 p.m. Jan. 10, 2014 - Zacks.com
Aegerion Gives Preliminary 2013 Update - Analyst Blog 5:10 p.m. Jan. 10, 2014 - Zacks.com
ENDP Agrees to Sell HealthTronics Unit - Analyst Blog 11:40 a.m. Jan. 10, 2014 - Zacks.com
SA PRO: Top Long And Short Ideas, Thursday January 9 7:30 a.m. Jan. 10, 2014 - Seeking Alpha
NuPathe Soars on Teva Offer - Analyst Blog 3:05 p.m. Jan. 9, 2014 - Zacks.com
Forest Labs Soars on Aptalis Deal - Analyst Blog 1:10 p.m. Jan. 9, 2014 - Zacks.com
Update on AMAG's Feraheme - Analyst Blog 1:00 p.m. Jan. 9, 2014 - Zacks.com
Positive Data on BioSpecifics/ Auxilium's Xiaflex - Analyst Blog 12:10 p.m. Jan. 9, 2014 - Zacks.com
NPSP Provides Rosy Gattex Outlook, Shares up - Analyst Blog 11:40 a.m. Jan. 9, 2014 - Zacks.com
Forest Branches Out With $2.9B Purchase of Rival 9:48 a.m. Jan. 9, 2014 - Barrons.com
Wall Street Breakfast: Must-Know News 6:33 a.m. Jan. 9, 2014 - Seeking Alpha
New Data on Pacira's Exparel - Analyst Blog 6:11 p.m. Jan. 8, 2014 - Zacks.com
Oculus Introduces Two Products - Analyst Blog 5:10 p.m. Jan. 8, 2014 - Zacks.com
AZN and Horizon Discovery Ink Deal - Analyst Blog 5:02 p.m. Jan. 8, 2014 - Zacks.com
Affymetrix Up on Upbeat Rev Guidance - Analyst Blog 4:45 p.m. Jan. 8, 2014 - Zacks.com
FDA lists four new drugs mentioned in Paragraph IV ANDAs 3:59 p.m. Jan. 8, 2014 - Seeking Alpha
Valeant Provides Strong Guidance, Shares Up - Analyst Blog 2:20 p.m. Jan. 8, 2014 - Zacks.com
The Deal: Forest Widens Business, Pays $2.9 Billion for Aptalis 2:06 p.m. Jan. 8, 2014 - TheStreet.com
Forest Buying Aptalis; Teva Bids For NuPathe Vs. Endo 10:24 a.m. Jan. 8, 2014 - Investors Business Daily


Forest Laboratories Pursues Additional Market Exclusivity to Extend Namenda Patent 8:30 a.m. Today - BusinessWire - BZX
Adamas Pharmaceuticals Earns $40 Million in Milestone Payments from Forest Laboratories for MDX-8704 9:00 a.m. Jan. 9, 2014 - PR Newswire
Trevena Announces Dosing of First Patient in Phase 2b BLAST-AHF Trial of TRV027 for Acute Heart Failure 6:59 a.m. Jan. 9, 2014 - BusinessWire
Aptalis to be Acquired by Forest Laboratories for $2.9 Billion 7:36 a.m. Jan. 8, 2014 - BusinessWire
Forest Laboratories to Acquire Aptalis for $2.9 Billion in Cash 7:29 a.m. Jan. 8, 2014 - BusinessWire
Stock Price Movement, Financial Reports Schedules, Conference Participation, Leadership Changes, and Donation - Research Report on Biogen Idec, Forest, PerkinElmer, Techne, and USANA 8:00 a.m. Jan. 7, 2014 - PR Newswire
moksha8 files for regulatory approval of Viibryd® and Colobreathe in Brazil and amends alliance with Forest Laboratories 8:00 a.m. Jan. 6, 2014 - PR Newswire
Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2014 Third Quarter Earnings 3:59 p.m. Jan. 2, 2014 - BusinessWire
Drug Availability, Clinical Trial Partnerships, Labeling Discussions, Stock Updates, and Credit Facilities - Research Report on Forest Laboratories, Oxygen Biotherapeutics, Alimera, pSivida and AcelRx 8:00 a.m. Dec. 24, 2013 - PR Newswire
Forest Announces New FETZIMA(TM) (levomilnacipran ER capsules) Now Available in Pharmacies Throughout U.S. 8:00 a.m. Dec. 19, 2013 - BusinessWire
Stock Price Updates, Dividends Declaration, and Appointments in Executive Leadership Team - Research Report on Humana, Illumina, Forest Laboratories, Stryker, and Unilife 8:00 a.m. Dec. 16, 2013 - PR Newswire
Forest Laboratories Announces Appointments to its Executive Team 9:00 a.m. Dec. 9, 2013 - BusinessWire
Proposed Offering and Amendments, Patents, Results, and Announcements by Healthcare Companies - Research Report on Forest Laboratories, OncoMed, EnteroMedics, Cadence, and Amarin 8:00 a.m. Dec. 6, 2013 - PR Newswire
Forest Laboratories, Inc. Upsizes and Prices Offering of $1.2 Billion of Senior Notes Due 2021 4:36 p.m. Dec. 5, 2013 - BusinessWire
Marketing Rights Acquisitions, PDUFA Date Extensions, Accountable Care Relationship and Stock Price Updates - Research Report on Forest Laboratories, Biogen, Bristol-Myers, Express Scripts, and Aetna 8:00 a.m. Dec. 5, 2013 - PR Newswire
Forest to Acquire U.S. Marketing Rights to Saphris(R) (asenapine) from Merck 9:00 a.m. Dec. 2, 2013 - BusinessWire
Forest Laboratories, Inc. Announces Private Placement of Senior Notes and Amendment to Existing $750 Million Revolver 8:30 a.m. Dec. 2, 2013 - BusinessWire
Forest Announces Major New Plans to Streamline Operations, Leverage Balance Sheet and Repurchase Common Stock 8:30 a.m. Dec. 2, 2013 - BusinessWire
Product Reviews, Recognitions, FDA Responses, and New Leadership Appointments - Research Report on Gilead, WellPoint, Questcor, Forest Laboratories, and Envision Healthcare 8:00 a.m. Nov. 27, 2013 - PR Newswire
Today's Research: Celgene Corp., Forest Laboratories Inc., Edwards Lifesciences Corp., and Peregrine Pharma Inc. 1:30 p.m. Nov. 22, 2013 - PR Newswire